RY / FA
Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q2 Q3 Δ in %
EV/EBITDA 304.63 84.75 20.95
Graham Fair Price 3.11 70.97 68.83
PEG 156.19 1.91 0.75
Price/Book 31.82 1.63 1.24
Price/Cash Flow 50.69 21.62 14.35
Prices/Earnings 25.46 11.84 9.44
Price/Sales 24.55 12.70 10.20
Price/FCF 50.69 21.62 14.35
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q2 Q3 Δ in %
Gross Profit Margin 0.00 1.00 1.00
Operating Margin -76.75 0.32 1.38
ROA 5.14 < 0.005 < 0.005
ROE 0.03 0.03 5.07
ROIC 0.03 < 0.005 -74.37
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q2 Q3 Δ in %
Debt QOQ -0.03 0.05 -45.07
Dividends QOQ -0.32 -0.02 94.42
EBIT QOQ < 0.005 -0.75 8418.10
EPS QOQ 0.13 0.06 -51.03
FCF QOQ -0.44 -0.12 73.50
Revenue QOQ -0.10 0.07 -33.67
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q2 Q3 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 0.00 0.00 0.00
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.80 0.80 -0.71
Quick Ratio 3.19 3.37 5.61
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q2 Q3 Δ in %
Book Value 80.13 80.61 0.60
Cash 257.66 280.74 8.96
Capex -0.51 -0.40 21.51
Free Cash Flow 6.91 6.08 -12.00
Revenue 9.73 10.36 6.46
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q2 Q3 Δ in %
Current Ratio 3.19 3.37 5.61
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 13.83 50.42 264.63
Naive Interpretation Member
06 - Financial Health · Bad